featured
Heterozygous Germ Line CSF3R Variants as Risk Alleles for Development of Hematologic Malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Heterozygous Germ Line CSF3R Variants as Risk Alleles for Development of Hematologic Malignancies
Blood Adv 2020 Oct 27;4(20)5269-5284, AM Trottier, LJ Druhan, IL Kraft, A Lance, S Feurstein, M Helgeson, JP Segal, S Das, BR Avalos, LA GodleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.